Comment
Author: Admin | 2025-04-28
Barlow C, Cunnion R, Srinivasan S, Horobetz C, Asfour F, Francis J, Rock M, Makholm L, Egan M, Guzman C (2018) Azithromycin for early pseudomonas infection in cystic fibrosis the OPTIMIZE randomized trial. Am J Respir Crit Care Med 198:1177–1187Article CAS PubMed PubMed Central Google Scholar Mandhane PJ, de Silbernagel PPZ, Aung YN et al (2017) Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: a placebo-controlled randomized trial. PLoS One 12:e0182411Article PubMed PubMed Central CAS Google Scholar Levine A, Kori M, Kierkus J, Sigall Boneh R, Sladek M, Escher JC, Wine E, Yerushalmi B, Amil Dias J, Shaoul R, Veereman Wauters G, Boaz M, Abitbol G, Bousvaros A, Turner D (2019) Azithromycin and metronidazole versus metronidazole-based therapy for the induction of remission in mild to moderate paediatric Crohn’s disease: a randomised controlled trial. Gut 68:239–247Article CAS PubMed Google Scholar Liu S, Zheng Y, Wu X, Xu B, Liu X, Feng G, Sun L, Shen C, Li J, Tang B, Jacqz-Aigrain E, Zhao W, Shen A (2018) Early target attainment of azithromycin therapy in children with lower respiratory tract infections. J Antimicrob Chemother 73:2846–2850Article CAS PubMed Google Scholar Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, Tjhung I, Hare KM, Ware RS, Chang AB (2013) Long-term azithromycin for indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 1:610–620Article CAS PubMed Google
Add Comment